Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/04/2022* -- Results Q3 2022 -- 1.27 --
11/04/2022* 08:30 EST Earnings Call Q3 2022 -- -- --
08/04/2022 -- Results Q2 2022 1.20 1.22 -1.56%
08/04/2022 08:30 EST Earnings Call Q2 2022 -- -- --
05/05/2022 -- Results Q1 2022 1.32 1.22 7.95%
05/05/2022 08:30 EST Earnings Call Q1 2022 -- -- --
02/15/2022 -- Results Q4 2021 1.00 0.96 3.80%
02/15/2022 08:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/04/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/04/2022
Beat/Miss Upgrade
Return Since -14.29%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
URL https://www.zoetis.com
Investor Relations URL https://investor.zoetis.com
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Large Cap/Growth
Next Earnings Release Nov. 04, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 20, 2022

Dividends

Dividend Per Share (TTM) 1.15
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.573
Yield to Sector 0.4418
Yield to Industry 0.2914
Last Dividend Amt. 0.325
Dividend Frequency Quarterly
Last Ex-Dividend Date Jul. 20, 2022
Yield (TTM) 0.80%
Forward Yield 0.87%
Payout Ratio 25.98%
Cash Payout Ratio 38.00%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
12.17%
12.64%
35.55%
19.45%
55.71%
25.76%
48.25%
-38.46%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-22.58%
7.30%
4.68%
16.13%
25.06%
-6.73%
3.51%
66.74%
-23.58%
59.29%
-12.42%
222.6%
-41.84%
-24.64%
19.84%
-50.83%
-9.36%
25.37%
-10.37%
17.83%
40.45%
16.15%
31.06%
66.08%
13.84%
-2.95%
-60.23%
239.3%
-42.61%
57.96%
12.85%
30.48%
19.48%
As of September 27, 2022.

Profile

Edit
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
URL https://www.zoetis.com
Investor Relations URL https://investor.zoetis.com
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Large Cap/Growth
Next Earnings Release Nov. 04, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 20, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
MOO 109.97M USD 8.08%
HHL.TO 52.50M USD 4.82%
ABPRX 622.21M USD 3.63%
LMPLX 377.79M USD 3.21%
NUGO 46.28M USD 1.79%
FMGKX 448.13M USD 1.70%
XLV 557.46M USD 1.52%
IYH 43.56M USD 1.49%
VHT 250.12M USD 1.35%
MFELX 447.25M USD 1.26%
CNPFX 911.26M USD 0.86%
FBGKX 350.93M USD 0.85%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter ZTS Tweets